ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology

ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology

Date
April 28, 2021
Location
Philadelphia

PHILADELPHIA – April 28, 2021 – ERT, a global leader in clinical endpoint data solutions, today announced the close of its merger with Bioclinica, a technological and scientific leader in clinical imaging. This combination creates the global leader in clinical trial endpoint technology and leading partner to pharmaceutical and biotechnology companies, providing best-in-class technology, scientific and therapeutic expertise, and digital innovation with an unrelenting focus on customer service.

For more information, visit: ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology | ERT